These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35632533)

  • 1. The Impact of COVID-19 Vaccination in Changing the Adherence to Preventive Measures: Evidence from Italy.
    Corea F; Folcarelli L; Napoli A; Del Giudice GM; Angelillo IF
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intention to Receive the COVID-19 Vaccine Booster Dose in a University Community in Italy.
    Folcarelli L; Miraglia Del Giudice G; Corea F; Angelillo IF
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Behaviors and Attitudes in Response to COVID-19 Pandemic and Vaccination in Healthcare Workers and University Students in Italy.
    Della Polla G; Pelullo CP; Di Giuseppe G; Angelillo IF
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosters and time from the last anti-COVID-19 vaccine dose: lead public health choices by real-time epidemiological assessment.
    Russo AG; Murtas R; Tunesi S; Decarli A; Bergamaschi W
    Epidemiol Prev; 2022; 46(1-2):34-46. PubMed ID: 35354266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Reasons for Receiving the Second Booster Dose of the COVID-19 Vaccine in Adults and in People with Chronic Medical Conditions in Southern Italy.
    Miraglia Del Giudice G; Folcarelli L; Della Polla G; Napoli A; Angelillo IF
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
    Natarajan K; Prasad N; Dascomb K; Irving SA; Yang DH; Gaglani M; Klein NP; DeSilva MB; Ong TC; Grannis SJ; Stenehjem E; Link-Gelles R; Rowley EA; Naleway AL; Han J; Raiyani C; Benitez GV; Rao S; Lewis N; Fadel WF; Grisel N; Griggs EP; Dunne MM; Stockwell MS; Mamawala M; McEvoy C; Barron MA; Goddard K; Valvi NR; Arndorfer J; Patel P; Mitchell PK; Smith M; Kharbanda AB; Fireman B; Embi PJ; Dickerson M; Davis JM; Zerbo O; Dalton AF; Wondimu MH; Azziz-Baumgartner E; Bozio CH; Reynolds S; Ferdinands J; Williams J; Schrag SJ; Verani JR; Ball S; Thompson MG; Dixon BE
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):495-502. PubMed ID: 35358170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
    Enticott J; Gill JS; Bacon SL; Lavoie KL; Epstein DS; Dawadi S; Teede HJ; Boyle J;
    BMJ Open; 2022 Jan; 12(1):e057127. PubMed ID: 34980631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic Disparities in eHealth Literacy and Preventive Behaviors During the COVID-19 Pandemic in Hong Kong: Cross-sectional Study.
    Guo Z; Zhao SZ; Guo N; Wu Y; Weng X; Wong JY; Lam TH; Wang MP
    J Med Internet Res; 2021 Apr; 23(4):e24577. PubMed ID: 33784240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public perceptions, individual characteristics, and preventive behaviors for COVID-19 in six countries: a cross-sectional study.
    Fujii R; Suzuki K; Niimi J
    Environ Health Prev Med; 2021 Mar; 26(1):29. PubMed ID: 33657995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
    Wu J; Li Q; Silver Tarimo C; Wang M; Gu J; Wei W; Ma M; Zhao L; Mu Z; Miao Y
    Front Immunol; 2021; 12():781161. PubMed ID: 34912346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive Measures for SARS-CoV-2 in the Workplace and Vaccine Acceptance: Assessment of Knowledge, Attitudes and Behaviors of Workers in Southern Italy.
    Pelullo CP; Tortoriello P; Torsiello L; Lombardi C; Napolitano F; Di Giuseppe G
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36366380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Trust in Government and Practice of Preventive Measures During the COVID-19 Pandemic in Japan.
    Gotanda H; Miyawaki A; Tabuchi T; Tsugawa Y
    J Gen Intern Med; 2021 Nov; 36(11):3471-3477. PubMed ID: 34159544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge into the Practice against COVID-19: A Cross-Sectional Study from Ghana.
    Yeboah P; Daliri DB; Abdin AY; Appiah-Brempong E; Pitsch W; Panyin AB; Adusei EBA; Razouk A; Nasim MJ; Jacob C
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting hand washing, mask wearing and social distancing behaviors among older adults during the covid-19 pandemic: an integrated social cognition model.
    Duan Y; Shang B; Liang W; Lin Z; Hu C; Baker JS; Wang Y; He J
    BMC Geriatr; 2022 Feb; 22(1):91. PubMed ID: 35109798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the anti-COVID-19 vaccination campaign in the Metropolitan Area of Milan (Lombardy Region, Northern Italy).
    Russo AG; Tunesi S; Consolazio D; Decarli A; Bergamaschi W
    Epidemiol Prev; 2021; 45(6):568-579. PubMed ID: 34791867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral Intention to Get a Booster Dose of COVID-19 Vaccine among Chinese Factory Workers.
    Zhang K; Fang Y; Chan PS; Cao H; Chen H; Hu T; Chen Y; Zhou X; Wang Z
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.